Aperion Trademark Details
Word Mark | Aperion |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Bristol-Myers Squibb Pharma Company of Wilmington, DE
View all trademarks for Bristol-Myers Squibb Pharma CompanyPrevious Owners
Dupont Pharmaceuticals Company of Wilmington, DE
View all trademarks for Dupont Pharmaceuticals CompanySerial Number | 76000864 |
---|---|
Status Date | Saturday, January 24, 2004 |
Filing Date | Saturday, January 24, 2004 |
Attorney | G Mathew Lombard |
Correspondent
G MATHEW LOMBARD
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK NY 10154
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK NY 10154
Case File Statements
Goods & Services | Pharmaceutical preparations, for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Monday, June 5, 2000 |
Primary Code | 005 |
Trademark Timeline
-
Mar 15 2000Trademark application filed with USPTO
-
Aug 22 2000Assigned To Examiner
-
Sep 05 2000Approved For Pub - Principal Register
-
Sep 29 2000Notice of Publication
-
Oct 31 2000Published For Opposition
-
Jan 23 2001Noa Mailed - Sou Required From Applicant
-
Jul 10 2001Extension 1 Filed
-
Jul 24 2001Extension 1 Granted
-
Jan 02 2002Extension 2 Filed
-
Jan 18 2002Extension 2 Granted
-
Jun 24 2002Extension 3 Filed
-
Jun 24 2002Teas Extension Received
-
Jul 05 2002Extension 3 Granted
-
Jul 24 2002Teas Change of Correspondence Received
-
Jan 17 2003Extension 4 Filed
-
Jan 17 2003Teas Extension Received
-
Mar 19 2003Extension 4 Granted
-
Jun 27 2003Extension 5 Filed
-
Jun 27 2003Teas Extension Received
-
Jul 08 2003Extension 5 Granted
-
Mar 17 2004Abandonment - No Use Statement Filed